Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma

Allergy. 2020 Apr;75(4):959-962. doi: 10.1111/all.14084. Epub 2019 Oct 31.

Authors

Jin An¹, Ji-Hyang Lee¹, Ha-Kyeong Won^{1

2}, Yewon Kang^{1

3}, Woo-Jung Song¹, Hyouk-Soo Kwon¹, You Sook Cho¹, Hee-Bom Moon¹, Tae-Bum Kim¹

Affiliations

¹ Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
² Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Korea.
³ Department of Internal Medicine, Pusan National University School of Medicine, Pusan, Korea.

PMID: 31605391
DOI: 10.1111/all.14084

No abstract available

Keywords: MRGPRX2; allergic asthma; biomarker; inhaled corticosteroid; prognosis.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Asthma* / diagnosis
Biomarkers
Cell Degranulation*
Humans
Nerve Tissue Proteins / blood*
Receptors, G-Protein-Coupled / blood*
Receptors, Neuropeptide / blood*

Substances

Biomarkers
MRGPRX2 protein, human
Nerve Tissue Proteins
Receptors, G-Protein-Coupled
Receptors, Neuropeptide